Department of Vascular Surgery, Peking Union Medical College Hospital, No. 1 Shuaifuyuan, Dongcheng District, Beijing, 100730, China.
Department of Radiology, Peking Union Medical College Hospital, No. 1 Shuaifuyuan, Dongcheng District, Beijing, 100730, China.
BMC Cardiovasc Disord. 2020 May 29;20(1):256. doi: 10.1186/s12872-020-01532-y.
Spontaneous isolated superior mesenteric artery dissection (SISMAD) is a rare vascular disorder, and the treatment strategies remain controversial. This study aimed to compare outcomes of conservative and endovascular treatments in symptomatic patients with SISMAD.
Forty-two consecutive SISMAD patients who were admitted to a single center between October 2009 and May 2018 were enrolled in this study. Based on their symptoms, 15 had conservative treatment, and 27 had endovascular treatment. The baseline characteristics, treatments, and follow-up results of the conservative group and endovascular group were analysed.
The rates of symptom relief were 93.3% in the conservative group and 96.3% in the endovascular group. The procedure-related complications in the endovascular group included one case of pseudoaneurysm formation in the left brachial artery. During the follow-up period (median 28.5 months), a higher proportion of patients in the conservative group had symptom recurrence (42.9% in the conservative group versus 4.8% in the endovascular group, p < 0.001). Four patients in the conservative group and one patient in the endovascular group had additional endovascular intervention during follow-up. Compared with the conservative group, patients in the endovascular group had statistically significantly longer symptom-free survival (p = 0.014) and a higher rate of superior mesenteric artery (SMA) remodeling (p < 0.001).
For symptomatic SISMAD, endovascularly treated patients had a lower rate of symptom recurrence and a higher rate of SMA remodeling in the long term. Prospective, multi-center studies are needed to confirm the long-term outcomes of both treatments.
自发性孤立性肠系膜上动脉夹层(SISMAD)是一种罕见的血管疾病,其治疗策略仍存在争议。本研究旨在比较保守治疗和血管内治疗对有症状的 SISMAD 患者的疗效。
本研究纳入了 2009 年 10 月至 2018 年 5 月期间在一家单中心就诊的 42 例连续 SISMAD 患者。根据症状,15 例患者接受了保守治疗,27 例患者接受了血管内治疗。分析了保守组和血管内组的基线特征、治疗和随访结果。
保守组症状缓解率为 93.3%,血管内组为 96.3%。血管内组的手术相关并发症包括一例左肱动脉假性动脉瘤形成。在随访期间(中位数 28.5 个月),保守组有更多的患者出现症状复发(保守组 42.9%,血管内组 4.8%,p<0.001)。保守组中有 4 例患者和血管内组中有 1 例患者在随访期间需要进一步的血管内干预。与保守组相比,血管内组患者的无病生存率显著延长(p=0.014),肠系膜上动脉(SMA)重塑率更高(p<0.001)。
对于有症状的 SISMAD,血管内治疗的患者在长期内症状复发率较低,SMA 重塑率较高。需要前瞻性、多中心研究来证实两种治疗方法的长期疗效。